Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

Go back to Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.13 +0.01 (0.89%)
Previous Close $1.12    52 Week High $3.85 
Open $1.13    52 Week Low $1.25 
Day High $1.15    P/E N/A 
Day Low $1.13    EPS $-0.28 
Volume 308,631